Waiving COVID-19 Vaccine Patents Isn't the Way to Inoculate the World
Such calls are well intentioned. Countries like the US and the UK have surged ahead with their vaccinations, cutting their deaths and hospitalizations dramatically. Meanwhile, India is in the throes of a catastrophic second wave as it struggles to vaccinate its enormous population. I've practiced patent law for 20 years. In that time I've managed the worldwide patent portfolio for Prevnar 13, the world's top-selling vaccine before COVID-19, before it was acquired by Pfizer. I've worked with scientists and executives to determine the best avenues for protecting vaccine components and manufactu...
Source: businessinsider.com